Clinical trialNCT06127199RecruitingInterventional

Contraceptive Efficacy Study of Ovaprene

SponsorDaré Bioscience, Inc.Enrollment656Contraception

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This will be a multi-center, single arm, open-label study of Ovaprene, a non-hormonal intravaginal ring, to investigate the contraceptive effectiveness, safety and acceptability of Ovaprene.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

Christine Mauck, MD
Daré Bioscience, Inc.
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

27 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Precision Trials Az
Phoenix, Arizona, United States
Valerie Sorkin-Wells, MD
Recruiting
Momdoc Women'S Health Research
Scottsdale, Arizona, United States
Completed
del Sol Research Management, Llc
Tucson, Arizona, United States
C. Paige Brainard, MD
Recruiting
Essential Health Access (berkeley)
Berkeley, California, United States
Completed
Essential Access Health
Los Angeles, California, United States
Completed
Amicis Research Center
Newhall, California, United States
Jerry Izu, MD
Recruiting
University of California at Davis
Sacramento, California, United States
Completed
University of California, San Francisco
San Francisco, California, United States
Withdrawn
University of Colorado Denver
Aurora, Colorado, United States
Completed
Emory University
Atlanta, Georgia, United States
Completed
University of Hawaii
Honolulu, Hawaii, United States
Completed
Praetorian Pharmaceutical Research, Llc
Marrero, Louisiana, United States
Completed
the Johns Hopkins University
Baltimore, Maryland, United States
Completed
Boston Medical Center
Boston, Massachusetts, United States
Completed
Washington University
St Louis, Missouri, United States
Completed
Rutgers Medical Center
Newark, New Jersey, United States
Completed
Columbia University
New York, New York, United States
Completed
Einstein College of Medicine
The Bronx, New York, United States
Completed
Carolina Women'S Research and Wellness Center
Durham, North Carolina, United States
Completed
University of Cincinnati
Cincinnati, Ohio, United States
Completed
Case Western
Cleveland, Ohio, United States
Completed
Oregon Health and Science University
Portland, Oregon, United States
Completed
University of Pennsylvania Penn Obstetric Gynecology Associates
Philadelphia, Pennsylvania, United States
Completed
Magee-Women'S Hospital
Pittsburgh, Pennsylvania, United States
Completed
University of Utah
Salt Lake City, Utah, United States
Completed
Eastern Virginia Medical School
Norfolk, Virginia, United States
Completed
Seattle Clinical Research Center
Seattle, Washington, United States
Ashley Fuller, MD
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 19 Dec 2023
Primary completion: 30 Apr 2027
Completion: 30 Sept 2027
Last update posted: 8 Oct 2026
Registered enrollment: 656
Registry id: NCT06127199

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.